Chargement en cours...

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?

Immune checkpoint inhibitors have significantly improved overall survival with an acceptable safety profile in a substantial proportion of non-small cell lung cancer (NSCLC) patients. However, not all patients are sensitive to immune checkpoint blockade and, in some cases, programmed death 1 (PD-1)...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ther Adv Med Oncol
Auteurs principaux: Lazzari, Chiara, Karachaliou, Niki, Bulotta, Alessandra, Viganó, Mariagrazia, Mirabile, Aurora, Brioschi, Elena, Santarpia, Mariacarmela, Gianni, Luca, Rosell, Rafael, Gregorc, Vanesa
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5894901/
https://ncbi.nlm.nih.gov/pubmed/29662546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918762094
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!